Results of clinical trials with an allogeneic melanoma tumor cell lysate vaccine: Melacine®
- 19 November 2003
- journal article
- review article
- Published by Elsevier BV in Seminars in Cancer Biology
- Vol. 13 (6), 409-415
- https://doi.org/10.1016/j.semcancer.2003.09.004
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Immunotherapy as part of combinations for the treatment of cancerInternational Immunopharmacology, 2003
- Influence of TNFα and LTα single nucleotide polymorphisms on susceptibility to and prognosis in cutaneous malignant melanoma in the British populationEuropean Journal of Immunogenetics, 2002
- Melanoma Vaccines: Breakthrough or Bust?Cancer Investigation, 2002
- HLA Associations in the Antitumor Response Against Malignant MelanomaJournal of Immunotherapy, 1995
- A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma.The Journal of Experimental Medicine, 1995
- A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas.The Journal of Experimental Medicine, 1994
- Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor.Proceedings of the National Academy of Sciences of the United States of America, 1994
- Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes.The Journal of Experimental Medicine, 1994
- A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human MelanomaScience, 1991
- Treatment of Murine Leukaemia with X‐Rays and Homologous Bone Marrow: IIBritish Journal of Haematology, 1957